Company intelligence / Profile preview

Trust Therapeutics

Boston, Massachusetts, United Statestrusttherapeutics.com ↗

Ownership: Private
Development stage: Other

Overview

Trust Therapeutics provides teletherapy-based counseling services with a focus on multicultural competence, diversity awareness, and evidence-based psychotherapeutic modalities. The company serves youth, young adults, professionals, and school communities across Massachusetts through licensed therapists trained in multiple therapeutic approaches. No drug development or traditional biotech/pharma pipeline exists.

Therapeutic areas: Psychiatry
Modalities: Acceptance and Commitment Therapy (ACT)Cognitive Behavioral Therapy (CBT)Dialectical Behavioral Therapy (DBT)Person-Centered TherapyNarrative TherapyMotivational InterviewingInternal Family Systems Therapy (IFS)Multicultural Counseling CompetenciesStrength-Based Approach
Industry: Non-Academic Healthcare

Partnerships

Fenway High School

Beyond the preview

Go deeper on Trust Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trust Therapeutics.

Explore the full profile